CrushSCI.com
120.6平均天数
91.5中位天数
30最短天数
226最长天数
4532025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

89 天

Relationships among nitrous oxide exposure, neurological injury and biomarkers

作者
Laxna Bhujel; Angela L. Chiew; Bhashita Jagarlamudi; Pramod Chandru; Naren Gunja; Nancy Briggs; Betty S. Chan展开收起
作者单位
1. Faculty of Medicine and Health, School of Clinical Medicine University of New South Wales Sydney New South Wales Australia; 2. Clinical Toxicology Unit and Emergency Department Prince of Wales Hospital Sydney New South Wales Australia; 3. Department of Clinical Pharmacology and Toxicology Therapeutics Centre St Vincent's Hospital Darlinghurst New South Wales Australia; 4. Department of Clinical Toxicology Westmead Hospital Westmead New South Wales Australia; 5. Emergency Department, Clinical Toxicology Unit Nepean Hospital Kingswood New South Wales Australia; 6. Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia; 7. Stats Central, Mark Wainwright Analytical Centre University of New South Wales Sydney New South Wales Australia展开收起
官方全文证据 DOI 网页
94 天

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

作者
Tanja Mueller; Christine Crearie; Liya Lu; Jiafeng Pan; Fraser N. Sneden; David Martin; Amanj Kurdi; Catherine S. Thomson; Julie Clarke; Marion Bennie展开收起
作者单位
1. Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK; 2. Public Health Scotland Glasgow/Edinburgh UK; 3. NHS Greater Glasgow and Clyde Glasgow UK展开收起
官方全文证据 DOI 网页
226 天

Monitoring pharmacodynamic and molecular drug targets in liquid biopsy: Exploratory study in liver cancer with modelling of EGFR Receptor engagement

作者
Zubida M. Al‐Majdoub; Armin Sepp; Amin Rostami‐Hodjegan; Brahim Achour展开收起
作者单位
1. Centre for Applied Pharmacokinetic Research, School of Health Sciences University of Manchester Manchester UK; 2. Certara Predictive Technologies Certara UK Sheffield UK; 3. Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy the University of Rhode Island Kingston Rhode Island USA展开收起
官方全文证据 DOI 网页
30 天

Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study

作者
Tianshu Gu; Yang Chen; Nan Zhang; Uazman Alam; Riccardo Proietti; Tong Liu; Kang‐Yin Chen; Gregory Y. H. Lip展开收起
作者单位
1. Liverpool Centre for Cardiovascular Science at University of Liverpool Liverpool John Moores University and Liverpool Heart and Chest Hospital Liverpool UK; 2. Tianjin Key Laboratory of Ionic‐Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology The Second Hospital of Tianjin Medical University Tianjin China; 3. Department of Cardiovascular and Metabolic Medicine University of Liverpool Liverpool UK; 4. Liverpool Centre for Cardiovascular Sciences University of Liverpool and Liverpool University Hospitals NHS Foundation Trust Liverpool UK; 5. Centre for Biomechanics and Rehabilitation Technologies Staffordshire University Stoke‐on‐Trent UK; 6. Department of Clinical Medicine Aalborg University Aalborg Denmark; 7. Department of Cardiology, Lipidology and Internal Medicine with Intensive Coronary Care Unit Medical University of Bialystok Bialystok Poland展开收起
官方全文证据 DOI 网页
172 天

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

作者
Anna Lundahl; Jonathan Grigg; Lubna Abuqayyas; Piotr Kuna; Gillian Hunter; Beata Pawlikowska; Jacob Leander; Michael Levin; Atul Gupta; James Paton; Katharine C. Pike; Jane R. Parnes; Gun Almqvist; Stephanie L. Roseti; the study investigators展开收起
作者单位
1. Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D AstraZeneca Gothenburg Sweden; 2. Centre for Genomics and Child Health, Blizard Institute Queen Mary University of London London UK; 3. Clinical Pharmacology, Modeling and Simulation Amgen Cambridge Massachusetts USA; 4. Department of Internal Medicine, Asthma and Allergy Medical University of Łódź Łódź Poland; 5. Biometrics, Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca Cambridge UK; 6. Biometrics, Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca Warsaw Poland; 7. Division of Paediatric Allergology University of Cape Town Cape Town South Africa; 8. Department of Paediatric Respiratory Medicine King's College Hospital London UK; 9. Faculty of Life Sciences and Medicine King's College London London UK; 10. School of Medicine, College of Medical, Veterinary & Life Sciences University of Glasgow Glasgow UK; 11. Department of Paediatric Respiratory Medicine Bristol Royal Hospital for Children Bristol UK; 12. Early Development Amgen Thousand Oaks California USA; 13. Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden; 14. Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca Gaithersburg Maryland USA展开收起
官方全文证据 DOI 网页
222 天

Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus

作者
Nele Goeyvaerts; Per Olsson Gisleskog; Martine Neyens; Juan José Perez Ruixo; Saberi Rana Ali; Iolanda Cirillo; Oliver Ackaert展开收起
作者单位
1. Johnson & Johnson Beerse Belgium; 2. POG Pharmacometrics London UK; 3. Johnson & Johnson Madrid Spain; 4. Johnson & Johnson Titusville New Jersey USA; 5. Johnson & Johnson Raritan New Jersey USA展开收起
官方全文证据 DOI 网页

FAQ

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY审稿要多久?

截至2026-11-17,CrushSCI 收录了 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 的 10 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study,2026-05-26 收稿,2026-06-25 录用),最慢一篇用了 226 天;平均 120.6 天,中位数 91.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。